| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Workforce Management Solutions |
|
Digg It - Workforce Management Solutions
Delegation is the buzzword when talking about workforce management solutions. Delegation is the According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product process by which authority is granted to a subordinate by his superior. But for delegation of ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in authority, organizations would remain forever small. Delegation is the only solution to cope wi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. h the increasing workload of managers as the organization grows. Because of the constraints of here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe time and availability, a manager cannot perform all the tasks himself. Therefore, he delegates d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro a certain amount of tasks to subordinates. Authority, on the other hand, is the right to comman ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc d. It is the discretion power vested with a manager to use organizational resources. Managers a easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi quire authority by virtue of rank or title associated with this position. Authority is granted nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically to individuals in a formal way in the organization. It flows from the top to down in the organi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ation structure. Responsibility, on the other hand, is obligation to perform tasks and account ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi for their satisfactory completion. It is implied that an individual is expected to fulfill cer ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a tain job requirements when accepting a position in an organization. In other words, the individ dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod al has to answer for the results of a task about to be performed. In contrast to authority, the cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin responsibility of an individual in the organization is always upwards; that is, the subordinat tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen is responsible to his or her superior. This is a crucial step in that a few important questio t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ns like what to delegate? When to delegate? Whom to delegate? And how to delegate are answered. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust The effectiveness of delegation depends on how clearly these questions are answered. First of a y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ll, the manager has to decide the tasks to be delegated to the subordinates. For this, he must . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e able to distinguish between the routine and non-routine tasks. The subordinate can perform ro elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip utine and single tasks, while the manager must perform the non-routine and very important tasks tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Bookkeeping Services Must Be Perfect To Be Successful Various Levels Of Six Sigma Certification
|